PHARMACOTHERAPY. A PATHOPHYSIOLOGIC APPROACH. 11TH EDITION

PHARMACOTHERAPY. A PATHOPHYSIOLOGIC APPROACH. 11TH EDITION

Editorial:
MCGRAW HILL
Año de edición:
Materia
Psicología
ISBN:
978-1-260-11681-6
Páginas:
2688
N. de edición:
11
Idioma:
Inglés
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

142,30 €

Despues:

135,19 €

• Section 1: Foundation Issues Updated!
Chapter 1: The Patient Care Process Updated!
Chapter 2: Health Literacy and Medication Use
Chapter 3: Cultural Competency Updated!
Chapter 4: Medication Safety Principles and Practices New!
Chapter 5: Clinical Pharmacokinetics and Pharmacodynamics New!
Chapter 6: Critical Care: Pain, Agitation, and Delirium New!
Chapter 6: Pharmacogenetics New!
Chapter 7: Clinical Toxicology
• Section 2: Common Health Problems
Chapter e9: Pain and Headache
Chapter e10: Minor Ophthalmic Disorders New!
Chapter e11: Minor Otic Disorders
Chapter e12: Cough and Other Nonspecific Respiratory Symptoms New!
Chapter e13: Allergic Rhinitis
Chapter e14: Oral Health and Systemic Conditions
Chapter e15: Oral Hygiene and Minor Oral Disorders
Chapter e16: Skin Care and Minor Dermatologic Conditions
Chapter e17: Travel Health
Chapter 18: Contraception
• Section 3: Special Populations New!
Chapter e19: Pediatrics: General Topics in Pediatric Pharmacotherapy New!
Chapter e20: Pediatrics: Oral Nutrition and Rehydration of Infants and
Children Chapter e22: Geriatrics: The Aging Process in Humans and Its Effects on Physiology
Chapter e23: Prescribing in the Older Adult
Chapter e28: Palliative Care
• Section 4: Cardiovascular Disorders
Chapter e29: Assessment of the Cardiovascular System Updated!
Chapter 30: Hypertension
Chapter 31: Dyslipidemia Updated!
Chapter 32: Stable Ischemic Heart Disease
Chapter 33: Acute Coronary Syndrome
Chapter e34: Peripheral Arterial Disease
Chapter 35: Chronic Heart Failure
Chapter 36: Acute Decompensated Heart Failure
Chapter 37: Venous Thromboembolism
Chapter 38: Stroke
Chapter 40: Cardiac Arrest
Chapter 41: Shock Syndromes
• Section 5: Respiratory Disorders Updated!
Chapter e42: Evaluation of Respiratory Function
Chapter 45: Pulmonary Arterial Hypertension
Chapter 46: Cystic Fibrosis
Chapter e47: Drug-Induced Pulmonary Diseases
• Section 6: Gastrointestinal Disorders
Chapter e48: Evaluation of the Gastrointestinal Tract
Chapter 49: Gastroesophageal Reflux Disease
Chapter 50: Peptic Ulcer Disease and Related Disorders
Chapter 51: Inflammatory Bowel Disease
Chapter 52: Nausea and Vomiting
Chapter 53: Diarrhea, Constipation, and Irritable Bowel Syndrome
Chapter 54: Portal Hypertension and Cirrhosis
Chapter e55: Drug-Induced Liver Disease
Chapter 56: Pancreatitis
Chapter 57: Viral Hepatitis
Chapter 58: Celiac Disease
• Section 7: Renal Disorders New!
Chapter 60: Acute Kidney Injury New!
Chapter 61: Chronic Kidney Disease Updated!
Chapter 62: Hemodialysis and Peritoneal Dialysis
Chapter 63: Drug-Induced Kidney Disease New!
Chapter 64: Glomerular Diseases New!
Chapter 65: Drug Therapy Individualization for Patients with Chronic Kidney Disease New!
Chapter 66: Disorders of Sodium and Water Homeostasis New!
Chapter 67: Disorders of Calcium and Phosphorus Homeostasis New!
Chapter 68: Disorders of Potassium and Magnesium Homeostasis
• Section 8: Neurological Disorders
Chapter e70: Evaluation of Neurologic Illness
Chapter 71: Alzheimer Disease
Chapter 72: Multiple Sclerosis New!
Chapter 73: Epilepsy
Chapter 75: Acute Management of the Brain Injury Patient
Chapter 76: Parkinson Disease Updated!
Chapter 77: Pain Management
Chapter 78: Headache Disorders
• Section 9: Psychiatric Disorders Updated!
Chapter e79: Evaluation of Psychiatric Disorders Updated!
Chapter 80: Attention Deficit/Hyperactivity Disorder
Chapter 81: Eating Disorders
Chapter 82: Substance-Use Disorders: Overview of Depressants, Stimulants, and Hallucinogens
Chapter 83: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine
Chapter 84: Schizophrenia New!
Chapter 85: Major Depressive Disorder
Chapter 86: Bipolar Disorder
Chapter 87: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders
Chapter 88: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
Chapter 89: Sleep–Wake Disorders
Chapter 90: Intellectual and Developmental Disabilities: Down Syndrome and Autism Spectrum Disorder
• Section 10: Endocrinologic Disorders
Chapter 92: Thyroid Disorders
Chapter 93: Adrenal Gland Disorders
Chapter 94: Pituitary Gland Disorders
• Section 11: Gynecologic and Obsetric Disorders
Chapter 95: Pregnancy and Lactation: Therapeutic Considerations Updated!
Chapter 96: Menstruation-Related Disorders New!
Chapter e102: Function and Evaluation of the Immune System
Chapter 97: Endometriosis
Chapter 98: Hormone Therapy in Women
• Section 12: Urological Disorders
Chapter 99: Erectile Dysfunction New!
Chapter 100: Benign Prostatic Hyperplasia
Chapter 101: Urinary Incontinence
• Section 13: Immunologic Disorders
Chapter 103: Systemic Lupus Erythematosus New!
Chapter 105: Solid-Organ Transplantation
• Section 15: Ophthalmic Disorders
Chapter 110: Glaucoma New!
Chapter 111: Age-Related Macular Degeneration New!
Chapter e112: Drug-Induced Ophthalmic Disorders
• Section 16: Dermatologic Disorders
Chapter 113: Acne Vulgaris New!
Chapter 115: Atopic Dermatitis New!
Chapter 116: Alopecia
• Section 17: Hematologic Disorders
Chapter 118: Anemias New!
Chapter 119: Coagulation Disorders New!
Chapter e121: Drug-Induced Hematologic Disorders
• Section 18: Infectious Diseases
Chapter e122: Laboratory Tests to Direct Antimicrobial Pharmacotherapy
Chapter 123: Antimicrobial Regimen Selection
Chapter 124: Central Nervous System Infections
Chapter 125: Lower Respiratory Tract Infections
Chapter 126: Upper Respiratory Tract Infections
Chapter 127: Influenza
Chapter 128: Skin and Soft-Tissue Infections
Chapter 129: Infective Endocarditis
Chapter 130: Tuberculosis
Chapter 131: Gastrointestinal Infections and Enterotoxigenic Poisonings
Chapter 132: Intra-Abdominal Infections
Chapter e133: Parasitic Diseases
Chapter 134: Urinary Tract Infections and Prostatitis
Chapter 135: Sexually Transmitted Infections
Chapter 136: Bone and Joint Infections
Chapter 137: Sepsis and Septic Shock
Chapter 138: Superficial Fungal Infections Updated!
Chapter 139: Invasive Fungal Infections
Chapter 140: Infections in Immunocompromised Patients
Chapter 141: Antimicrobial Prophylaxis in Surgery
Chapter 142: Vaccines and Immunoglobulins
Chapter 143: Human Immunodeficiency Virus Infection
• Section 19: Oncologic Disorders New!
Chapter 144: Cancer Treatment and Chemotherapy New!
Chapter 146: Lung Cancer New!
Chapter 147: Colorectal Cancer New!
Chapter 148: Prostate Cancer New!
Chapter 149: Lymphomas New!
Chapter 151: Acute Leukemias New!
Chapter e154: Myelodysplastic Syndromes New!
Chapter 157: Hematopoietic Stem Cell Transplantation
• Section 20: Nutritional Disorders New!
Chapter 158: Assessment of Nutrition Status and Nutrition Requirements New!
Chapter 159: Parenteral Nutrition New!
Chapter 160: Enteral Nutrition

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.
25+ additional chapters available online!
The classic guide to driving optimal patient outcomes using evidence-based medication therapies—updated with the latest advances and guidelines
A Doody's Core Title for 2020!
Presented in full color, Pharmacotherapy: A Pathophysiologic Approach, 11th Edition helps you deliver the highest-quality patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. It takes you beyond drug indications and dosages, showing how to properly select, administer, and monitor drugs—everything you need to provide safe, effective drug therapy across all therapeutic categories. With all-new monitoring tables and authoritative content from 300 expert contributors, this new edition has been fully updated to reflect the latest evidence-based information and recommendations. You’ll find Key Concepts at the beginning of each chapter, Clinical Presentation tables that summarize disease signs and symptoms, and Clinical Controversies boxes that examine the complicated issues faced by students and clinicians in providing drug therapy.
Why Pharmacotherapy: A Pathophysiologic Approach is perfect for students, pharmacists, and other healthcare providers:
• All chapters provide the most current, reliable, and relevant information available.
• Key concepts kick off every chapter.
• Clinical Presentation Tables summarize disease signs and symptoms.
• The majority of sections include personalized pharmacotherapy content.
• Clinical Controversies Boxes clarify the most complex drug therapy issues you’ll face.
• Diagnostic flow diagrams, treatment algorithms, dosing recommendations, and monitoring approaches have been updated in full color to distinguish treatment pathways.
• Most disease-oriented chapters are enhanced by updated evidence-based treatment guidelines, which often include ratings of the level of evidence to support key therapeutic approaches.
• Instructors who adopt this text are eligible for a PowerPoint presentation of all images and answers to Self-Assessment Questions!
The most trusted guide of its kind for decades, Pharmacotherapy: A Pathophysiologic Approach is the go-to text for students and practitioners seeking clear, objective coverage of core pathophysiologic and therapeutic elements.